----

----

----

| x      | Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934  |
|--------|------------------------------------------------------------------------------------|
|   |                                                                               |   |   |
|   |                                                                               | For the quarterly period ended June 30, 2013 |   |
|   |                                                                               |   |   |
| o      | Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|   |                                                                               |   |   |
|   |                                                                               | For the transition period from ______________ to _____________ |   |

----

| Nevada                   | 27-2969241               |
|--------------------------|--------------------------|
| (State of incorporation) | (IRS Employer ID Number) |

----

|   | Large accelerated filer    o           | Accelerated filer                          o |   |
|--------|-------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|   | Non-accelerated filer      o | Smaller reporting company        x                                                                                                     |   |

----

| 3.7   |   | Certificate of Amendment to Articles of Incorporation of SMSA Katy Acquisition Corp. as filed with the Secretary of State of Nevada on June 21, 2012 for the purpose of changing the name of the issuer to L2 Medical Development Company.  |
|------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1  |   | Certification pursuant to Section 302 of Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 31.1 of the Quarterly Report on Form 10-Q filed with the Commission on August 5, 2013).                                           |
| 32.1  |   | Certification pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 32.1 of the Quarterly Report on Form 10-Q filed with the Commission on August 5, 2013).                                                |

----

|                        | L2 Medical Development Company                                                                                                  |
|-----------------------------|---------------------------------------------------------------------------------------------------------------------------------|
|                        |                                                                                                                            |
| Dated: August 21, 2013 |        /s/ Matthew C. Lipton          |
|                        | Matthew C. Lipton                                                                                                               |
|                        | President, Chief Executive Officer,                                                                                             |
|                        | Chief Financial Officer and Sole Director                                                                                       |

----